🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose is to demonstrate the bioequivalence of naproxen admini...
Status
Completed
Location
Research Site
Start Date
2011-09
Trial ID
NCT01331993
Treatments Being Tested
This is a multicenter, safety and pharmacokinetic trial to determine the MT...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2014-04-29
Trial ID
NCT01748149
Treatments Being Tested
Study has two arms. Arm 1 has two cohorts in which each cohort, under the f...
Status
Completed
Location
Pfizer Clinical Research Unit - New Haven
Start Date
2025-02-04
Trial ID
NCT07117799
Treatments Being Tested
This is a phase 2, multicenter, single-arm study with a safety lead-in to i...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2022-06-02
Trial ID
NCT05195632
Treatments Being Tested
This is a single centre, proof-of-concept phase I trial of atezolizumab in ...
Status
Active Not Recruiting
Location
Royal Marsden Hospital NHS Foundation Trust
Start Date
2018-08-13
Trial ID
NCT03673787
Treatments Being Tested
This Pilot study will investigate the bioavailability in fasting women of 2...
Status
Completed
Location
Innolab
Start Date
2019-11-09
Trial ID
NCT04193852
The primary objective of this study is to evaluate the safety and efficacy ...
Status
Completed
Location
UCI Center for Clinical Research
Start Date
2021-06-28
Trial ID
NCT04886518
Treatments Being Tested
The central retinal vein occlusion (CRVO) is a major cause of ocular morbid...
Status
Unknown
Location
CHNO des Quinze-Vingts
Start Date
2015-12
Trial ID
NCT02957760
Treatments Being Tested
The study is designed as a randomized double-blind placebo-controlled clini...
Status
Active Not Recruiting
Location
Medical University of Gdańsk
Start Date
2023-12-01
Trial ID
NCT07411482
Treatments Being Tested
This study will be a two-part with an open-label, single oral dose, two-way...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02-11
Trial ID
NCT02371603